| Dr John P Rogers, MD | |
|
2025 Technology Pkwy, Suite G07, Mechanicsburg, PA 17050-9500 | |
| (717) 791-2440 | |
| (717) 791-2441 |
| Full Name | Dr John P Rogers |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 35 Years |
| Location | 2025 Technology Pkwy, Mechanicsburg, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760595219 | NPI | - | NPPES |
| 001759397 | Medicaid | PA | |
| 412162700 | Medicaid | MD |
| Facility Name | Location | Facility Type |
|---|---|---|
| Homeland Homehealth | Harrisburg, PA | Home health agency |
| Pinnacle Health Hospitals | Harrisburg, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fc Select Llc | 0648445163 | 90 |
| Pinnacle Health Medical Services | 7618960493 | 942 |
News Archive
Data from the recently completed randomised controlled trial has been presented at the ISSHP European Congress this September in Berlin, Germany. This interventional study evaluated the real life performance and clinical utility of the Roche Elecsys sFlt-1/PlGF ratio test in the guidance of admission of patients with suspicion of pre-eclampsia (PE) – a life threatening condition for pregnant women.
H&P Labs Inc. announced an agreement with Harvard University and Brigham and Women's Hospital to license two classes of compounds in order to develop an oral drug therapy against Ebola.
The children of traumatized people have long been known to be at increased risk for posttraumatic stress disorder (PTSD), and mood and anxiety disorders.
Imaxio, a biopharmaceutical company specializing in vaccines and genomics, announces today that IMX313, its proprietary pro-immunogenic technology, has been administered for the first time in humans in a tuberculosis vaccine phase I clinical study. The trial is being conducted by the Jenner Institute at Oxford University, England.
Associated Press: Health care reform hits another milestone next month, with new provisions that include a coverage expansion for young adults and restrictions on an insurer's ability to impose annual coverage limits or to reject children with pre-existing medical conditions. Insurance coverage that starts on or after Sept. 23 will have to comply with these changes and others that were put in place when President Barack Obama signed the health overhaul into law March 23." Many plans won't renew until later on (Murphy, 8/3).
› Verified 9 days ago
| Entity Name | Pinnacle Health Emergency Department Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487693404 PECOS PAC ID: 0143124701 Enrollment ID: O20031125000218 |
News Archive
Data from the recently completed randomised controlled trial has been presented at the ISSHP European Congress this September in Berlin, Germany. This interventional study evaluated the real life performance and clinical utility of the Roche Elecsys sFlt-1/PlGF ratio test in the guidance of admission of patients with suspicion of pre-eclampsia (PE) – a life threatening condition for pregnant women.
H&P Labs Inc. announced an agreement with Harvard University and Brigham and Women's Hospital to license two classes of compounds in order to develop an oral drug therapy against Ebola.
The children of traumatized people have long been known to be at increased risk for posttraumatic stress disorder (PTSD), and mood and anxiety disorders.
Imaxio, a biopharmaceutical company specializing in vaccines and genomics, announces today that IMX313, its proprietary pro-immunogenic technology, has been administered for the first time in humans in a tuberculosis vaccine phase I clinical study. The trial is being conducted by the Jenner Institute at Oxford University, England.
Associated Press: Health care reform hits another milestone next month, with new provisions that include a coverage expansion for young adults and restrictions on an insurer's ability to impose annual coverage limits or to reject children with pre-existing medical conditions. Insurance coverage that starts on or after Sept. 23 will have to comply with these changes and others that were put in place when President Barack Obama signed the health overhaul into law March 23." Many plans won't renew until later on (Murphy, 8/3).
› Verified 9 days ago
| Entity Name | Pinnacle Health Medical Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932143427 PECOS PAC ID: 7618960493 Enrollment ID: O20040407000180 |
News Archive
Data from the recently completed randomised controlled trial has been presented at the ISSHP European Congress this September in Berlin, Germany. This interventional study evaluated the real life performance and clinical utility of the Roche Elecsys sFlt-1/PlGF ratio test in the guidance of admission of patients with suspicion of pre-eclampsia (PE) – a life threatening condition for pregnant women.
H&P Labs Inc. announced an agreement with Harvard University and Brigham and Women's Hospital to license two classes of compounds in order to develop an oral drug therapy against Ebola.
The children of traumatized people have long been known to be at increased risk for posttraumatic stress disorder (PTSD), and mood and anxiety disorders.
Imaxio, a biopharmaceutical company specializing in vaccines and genomics, announces today that IMX313, its proprietary pro-immunogenic technology, has been administered for the first time in humans in a tuberculosis vaccine phase I clinical study. The trial is being conducted by the Jenner Institute at Oxford University, England.
Associated Press: Health care reform hits another milestone next month, with new provisions that include a coverage expansion for young adults and restrictions on an insurer's ability to impose annual coverage limits or to reject children with pre-existing medical conditions. Insurance coverage that starts on or after Sept. 23 will have to comply with these changes and others that were put in place when President Barack Obama signed the health overhaul into law March 23." Many plans won't renew until later on (Murphy, 8/3).
› Verified 9 days ago
| Entity Name | Pinnacle Health Regional Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013441690 PECOS PAC ID: 7416228358 Enrollment ID: O20170810001731 |
News Archive
Data from the recently completed randomised controlled trial has been presented at the ISSHP European Congress this September in Berlin, Germany. This interventional study evaluated the real life performance and clinical utility of the Roche Elecsys sFlt-1/PlGF ratio test in the guidance of admission of patients with suspicion of pre-eclampsia (PE) – a life threatening condition for pregnant women.
H&P Labs Inc. announced an agreement with Harvard University and Brigham and Women's Hospital to license two classes of compounds in order to develop an oral drug therapy against Ebola.
The children of traumatized people have long been known to be at increased risk for posttraumatic stress disorder (PTSD), and mood and anxiety disorders.
Imaxio, a biopharmaceutical company specializing in vaccines and genomics, announces today that IMX313, its proprietary pro-immunogenic technology, has been administered for the first time in humans in a tuberculosis vaccine phase I clinical study. The trial is being conducted by the Jenner Institute at Oxford University, England.
Associated Press: Health care reform hits another milestone next month, with new provisions that include a coverage expansion for young adults and restrictions on an insurer's ability to impose annual coverage limits or to reject children with pre-existing medical conditions. Insurance coverage that starts on or after Sept. 23 will have to comply with these changes and others that were put in place when President Barack Obama signed the health overhaul into law March 23." Many plans won't renew until later on (Murphy, 8/3).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John P Rogers, MD 2025 Technology Pkwy Ste G07, Mechanicsburg, PA 17050-9400 Ph: () - | Dr John P Rogers, MD 2025 Technology Pkwy, Suite G07, Mechanicsburg, PA 17050-9500 Ph: (717) 791-2440 |
News Archive
Data from the recently completed randomised controlled trial has been presented at the ISSHP European Congress this September in Berlin, Germany. This interventional study evaluated the real life performance and clinical utility of the Roche Elecsys sFlt-1/PlGF ratio test in the guidance of admission of patients with suspicion of pre-eclampsia (PE) – a life threatening condition for pregnant women.
H&P Labs Inc. announced an agreement with Harvard University and Brigham and Women's Hospital to license two classes of compounds in order to develop an oral drug therapy against Ebola.
The children of traumatized people have long been known to be at increased risk for posttraumatic stress disorder (PTSD), and mood and anxiety disorders.
Imaxio, a biopharmaceutical company specializing in vaccines and genomics, announces today that IMX313, its proprietary pro-immunogenic technology, has been administered for the first time in humans in a tuberculosis vaccine phase I clinical study. The trial is being conducted by the Jenner Institute at Oxford University, England.
Associated Press: Health care reform hits another milestone next month, with new provisions that include a coverage expansion for young adults and restrictions on an insurer's ability to impose annual coverage limits or to reject children with pre-existing medical conditions. Insurance coverage that starts on or after Sept. 23 will have to comply with these changes and others that were put in place when President Barack Obama signed the health overhaul into law March 23." Many plans won't renew until later on (Murphy, 8/3).
› Verified 9 days ago
Manuela Maria Orzea Modelewski, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1995 Technology Pkwy, Mechanicsburg, PA 17050 Phone: 717-231-8772 | |
Paul Modelewski, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1995 Technology Pkwy, Mechanicsburg, PA 17050 Phone: 717-231-8772 | |
Dr. Marlys J Pike, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 6481 Carlisle Pike, Mechanicsburg, PA 17050 Phone: 717-796-9355 Fax: 717-620-8093 | |
Dr. Gregory J Smolin, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 6481 Carlisle Pike, Mechanicsburg, PA 17050 Phone: 717-516-6396 Fax: 717-620-8093 | |
Richard D Stagg, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 120 S Filbert St, Mechanicsburg, PA 17055 Phone: 717-795-6656 Fax: 717-795-6658 | |
Yolanda Marion Michetti, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2025 Technology Pkwy Ste G07, Mechanicsburg, PA 17050 Phone: 717-791-2440 Fax: 717-791-2441 | |
Roy E Monsour, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2025 Technology Pkwy Ste 301, Mechanicsburg, PA 17050 Phone: 717-642-5666 Fax: 717-642-4292 |